Compound Evidence File
#EC-2026-0632
Chonluten
Filed under Peptides. The bureau holds 196 laboratory returns for this compound from 84 distinct subjects. Scores below are per-subject aggregates; open a subject row for the underlying evidence.
Cross-Index
Subjects Shipping This Compound
84 SUBJECTS| Subject | Grade | Samples | Mean | Min | Max | First seen | Last seen |
|---|---|---|---|---|---|---|---|
| HomopeptideCASE #VI-2026-0760 | A | 7 | 10.0 | 9.9 | 10.0 | 23 May 2026 | 23 May 2026 |
| Tianjin Finder Chemical TFCCASE #VI-2026-0693 | A | 6 | 10.0 | 9.9 | 10.0 | 14 Nov 2025 | 16 Apr 2026 |
| Shanghai ERP BiotechnologyCASE #VI-2026-0936 | A | 4 | 10.0 | 10.0 | 10.0 | 27 Dec 2025 | 18 May 2026 |
| JEEP PeptidesCASE #VI-2026-0457 | A | 4 | 10.0 | 9.9 | 10.0 | 19 Dec 2025 | 8 Jun 2026 |
| Chinese Peptide CompanyCASE #VI-2026-0184 | A | 4 | 10.0 | 9.9 | 10.0 | 22 Jan 2026 | 9 Jul 2026 |
| Shanghai Sigma AudleyCASE #VI-2026-0505 | A | 4 | 10.0 | 9.9 | 10.0 | 26 Dec 2025 | 15 Jul 2026 |
| AmbioPharmCASE #VI-2026-0177 | A | 4 | 10.0 | 9.9 | 10.0 | 19 Jan 2026 | 14 Jun 2026 |
| QYAOBIOCASE #VI-2026-0861 | A | 3 | 10.0 | 9.9 | 10.0 | 15 Feb 2026 | 23 May 2026 |
| Hubei JianxiangCASE #VI-2026-0048 | A | 3 | 10.0 | 9.9 | 10.0 | 7 Jan 2026 | 16 Jun 2026 |
| WuXi TIDESCASE #VI-2026-0335 | A | 3 | 10.0 | 9.9 | 10.0 | 21 Dec 2025 | 19 Jun 2026 |
| Thermo Fisher ScientificCASE #VI-2026-0142 | A | 3 | 10.0 | 9.9 | 10.0 | 19 May 2026 | 14 Jul 2026 |
| Mokemei BiotechnologyCASE #VI-2026-0540 | A | 2 | 10.0 | 10.0 | 10.0 | 5 Apr 2026 | 19 May 2026 |
| Shanghai Wibson BiotechnologyCASE #VI-2026-0379 | A | 2 | 10.0 | 10.0 | 10.0 | 17 Mar 2026 | 25 May 2026 |
| Hybio PharmaceuticalCASE #VI-2026-0065 | A | 2 | 10.0 | 10.0 | 10.0 | 22 Jun 2026 | 6 Aug 2026 |
| Sigma-AldrichCASE #VI-2026-0829 | A | 2 | 10.0 | 10.0 | 10.0 | 4 Jun 2026 | 21 Jul 2026 |
| Laicuinuo LCNCASE #VI-2026-0223 | X | 1 | 10.0 | 10.0 | 10.0 | 25 Apr 2025 | 25 Apr 2025 |
| Eros PeptidesCASE #VI-2026-0918 | X | 1 | 10.0 | 10.0 | 10.0 | 8 Jul 2025 | 8 Jul 2025 |
| PeptiAtlasCASE #VI-2026-0739 | X | 1 | 10.0 | 10.0 | 10.0 | 16 Mar 2025 | 16 Mar 2025 |
| BachemCASE #VI-2026-0314 | A | 4 | 9.9 | 9.9 | 9.9 | 20 Nov 2025 | 16 Apr 2026 |
| PolyPeptide GroupCASE #VI-2026-0143 | A | 4 | 9.9 | 9.9 | 10.0 | 15 May 2026 | 14 Aug 2026 |
| Sangon BioCASE #VI-2026-0671 | A | 3 | 9.9 | 9.9 | 10.0 | 17 Jan 2026 | 3 May 2026 |
| Flourishglobal PeptideCASE #VI-2026-0630 | A | 3 | 9.9 | 9.9 | 10.0 | 5 Mar 2026 | 23 Jun 2026 |
| SinoPepCASE #VI-2026-0387 | A | 3 | 9.9 | 9.9 | 9.9 | 5 Mar 2026 | 20 Jun 2026 |
| Kerui PeptidesCASE #VI-2026-0626 | A | 2 | 9.9 | 9.9 | 10.0 | 28 May 2026 | 6 Jun 2026 |
| GenScript PeptidesCASE #VI-2026-0860 | A | 2 | 9.9 | 9.9 | 9.9 | 5 Apr 2026 | 28 Jul 2026 |
| AsymchemCASE #VI-2026-0091 | A | 2 | 9.9 | 9.9 | 10.0 | 1 Jul 2026 | 9 Jul 2026 |
| HazelCASE #VI-2026-0392 | X | 1 | 9.9 | 9.9 | 9.9 | 6 May 2025 | 6 May 2025 |
| Lisa BiopeptideCASE #VI-2026-0131 | X | 1 | 9.5 | 9.5 | 9.5 | 16 Mar 2025 | 16 Mar 2025 |
| PeptiSlimCASE #VI-2026-0557 | X | 3 | 9.1 | 8.7 | 9.4 | 8 Jul 2025 | 25 May 2026 |
| NUPEPS PeptidesCASE #VI-2026-0896 | X | 1 | 9.1 | 9.1 | 9.1 | 14 Jan 2025 | 14 Jan 2025 |
| TydesCASE #VI-2026-0493 | X | 1 | 9.0 | 9.0 | 9.0 | 20 Jun 2025 | 20 Jun 2025 |
| Glbiochem (Shanghai)CASE #VI-2026-0704 | A | 2 | 8.8 | 8.7 | 8.9 | 21 May 2026 | 21 May 2026 |
| Qingdao Sigma Chemical QSCCASE #VI-2026-0538 | A | 5 | 8.7 | 7.0 | 10.0 | 23 May 2026 | 23 May 2026 |
| Wuhan Wansheng Bio (WWB)CASE #VI-2026-0594 | A | 5 | 8.6 | 6.8 | 9.9 | 24 May 2026 | 24 May 2026 |
| Nantong Guangyuan Chemical GYCCASE #VI-2026-0284 | A | 3 | 8.3 | 8.1 | 8.4 | 23 May 2026 | 23 May 2026 |
| Diju Peptides Wellness and CoCASE #VI-2026-0724 | X | 1 | 8.2 | 8.2 | 8.2 | 27 Feb 2025 | 27 Feb 2025 |
| LipeptidesCASE #VI-2026-0863 | X | 1 | 8.2 | 8.2 | 8.2 | 2 Jul 2025 | 2 Jul 2025 |
| HkRoidsCASE #VI-2026-0784 | X | 1 | 8.2 | 8.2 | 8.2 | 25 Apr 2025 | 25 Apr 2025 |
| UtherCASE #VI-2026-0902 | X | 2 | 8.0 | 7.0 | 9.0 | 20 Jun 2025 | 24 May 2026 |
| Planet PeptideCASE #VI-2026-0092 | X | 2 | 8.0 | 6.3 | 9.7 | 21 May 2025 | 21 May 2026 |
| Shanghai Sigma Audley SSACASE #VI-2026-0486 | A | 5 | 7.9 | 7.1 | 9.3 | 24 May 2026 | 24 May 2026 |
| Xianhong Tong XHT PeptidesCASE #VI-2026-0997 | X | 1 | 7.9 | 7.9 | 7.9 | 21 May 2025 | 21 May 2025 |
| Tianjin Ruiwang New Material Technology CoCASE #VI-2026-0192 | X | 10 | 7.7 | 5.8 | 10.0 | 13 Feb 2025 | 23 May 2026 |
| BeiBangAnCASE #VI-2026-0899 | X | 1 | 7.7 | 7.7 | 7.7 | 21 May 2025 | 21 May 2025 |
| YB PeptideCASE #VI-2026-0813 | X | 1 | 7.6 | 7.6 | 7.6 | 2 Apr 2025 | 2 Apr 2025 |
| Anlv BiotechnologyCASE #VI-2026-0110 | X | 1 | 7.6 | 7.6 | 7.6 | 8 Jul 2025 | 8 Jul 2025 |
| Dankang BioHealthCASE #VI-2026-0775 | X | 1 | 7.4 | 7.4 | 7.4 | 16 Mar 2025 | 16 Mar 2025 |
| Zen PeptidesCASE #VI-2026-0940 | X | 1 | 7.2 | 7.2 | 7.2 | 6 May 2025 | 6 May 2025 |
| ScienceCASE #VI-2026-0636 | X | 1 | 7.1 | 7.1 | 7.1 | 13 Jun 2025 | 13 Jun 2025 |
| Peptide-SCASE #VI-2026-0111 | X | 10 | 6.9 | 4.9 | 8.6 | 6 May 2025 | 19 Jan 2026 |
| Limitless Life NootropicsCASE #VI-2026-0980 | X | 2 | 6.9 | 6.1 | 7.8 | 13 Feb 2025 | 26 Jan 2026 |
| UWA Elite PeptidesCASE #VI-2026-0130 | X | 1 | 6.9 | 6.9 | 6.9 | 24 Apr 2025 | 24 Apr 2025 |
| Peptide SciencesCASE #VI-2026-0867 | X | 2 | 6.8 | 5.9 | 7.8 | 13 Feb 2025 | 23 May 2026 |
| Amplified AminoCASE #VI-2026-0748 | X | 1 | 6.8 | 6.8 | 6.8 | 21 May 2025 | 21 May 2025 |
| Shenzhen Loga Tech LG LOGACASE #VI-2026-0920 | X | 2 | 6.7 | 5.5 | 7.8 | 3 Jun 2025 | 24 May 2026 |
| Rayshine Peptide BiochemicalsCASE #VI-2026-0545 | X | 1 | 6.7 | 6.7 | 6.7 | 17 Dec 2024 | 17 Dec 2024 |
| OmegAminoCASE #VI-2026-0014 | X | 1 | 6.7 | 6.7 | 6.7 | 24 Apr 2025 | 24 Apr 2025 |
| Changan District Sheng Peptide TradingCASE #VI-2026-0341 | X | 1 | 6.6 | 6.6 | 6.6 | 24 Apr 2025 | 24 Apr 2025 |
| Qing Li PeptideCASE #VI-2026-0469 | X | 7 | 6.5 | 3.5 | 8.3 | 16 Mar 2025 | 25 May 2026 |
| Biolongevity LabsCASE #VI-2026-0442 | X | 3 | 6.5 | 5.3 | 8.1 | 21 May 2025 | 24 May 2026 |
| ZLZ PeptideCASE #VI-2026-0524 | X | 2 | 6.3 | 5.1 | 7.6 | 6 May 2025 | 21 May 2026 |
| Qingdao Saber Technology Pharma QSTCASE #VI-2026-0467 | X | 1 | 6.3 | 6.3 | 6.3 | 16 Mar 2025 | 16 Mar 2025 |
| EHZ PeptidesCASE #VI-2026-0296 | X | 1 | 6.3 | 6.3 | 6.3 | 27 Feb 2025 | 27 Feb 2025 |
| Astro PeptidesCASE #VI-2026-0424 | X | 2 | 6.2 | 5.7 | 6.7 | 27 Feb 2025 | 19 Jan 2026 |
| Peptronix Bio PTBCASE #VI-2026-0979 | X | 1 | 6.2 | 6.2 | 6.2 | 2 Apr 2025 | 2 Apr 2025 |
| PurePeptidesCASE #VI-2026-0234 | X | 1 | 6.2 | 6.2 | 6.2 | 8 Jul 2025 | 8 Jul 2025 |
| TSC Top Supplements ChinaCASE #VI-2026-0523 | X | 4 | 6.0 | 5.5 | 6.5 | 3 Jun 2025 | 20 May 2026 |
| Shandong Aishi BiotechnologyCASE #VI-2026-0308 | X | 2 | 6.0 | 5.1 | 6.9 | 7 May 2025 | 21 May 2026 |
| Heman Peptide HMCASE #VI-2026-0089 | X | 2 | 5.9 | 5.8 | 6.1 | 11 Jun 2025 | 25 May 2026 |
| Regenerative ResearchCASE #VI-2026-0349 | X | 1 | 5.8 | 5.8 | 5.8 | 3 Jul 2025 | 3 Jul 2025 |
| DeuschemCASE #VI-2026-0004 | X | 1 | 5.8 | 5.8 | 5.8 | 28 Mar 2025 | 28 Mar 2025 |
| Shanghai OuDaXin New Material Technology CenterCASE #VI-2026-0498 | E | 2 | 5.6 | 5.6 | 5.6 | 2 Apr 2025 | 19 Jan 2026 |
| Hangzhou Youngpeptide Biotechnology HYBCASE #VI-2026-0347 | X | 1 | 4.7 | 4.7 | 4.7 | 28 Mar 2025 | 28 Mar 2025 |
| Coastal PeptidesCASE #VI-2026-0958 | X | 1 | 4.4 | 4.4 | 4.4 | 7 May 2025 | 7 May 2025 |
| Elite Research USACASE #VI-2026-0267 | X | 4 | 4.2 | 3.4 | 6.0 | 21 May 2025 | 19 Jan 2026 |
| Platinum CryoCASE #VI-2026-0406 | X | 1 | 3.7 | 3.7 | 3.7 | 21 May 2025 | 21 May 2025 |
| WllyBIOCASE #VI-2026-0470 | X | 1 | 3.6 | 3.6 | 3.6 | 21 May 2025 | 21 May 2025 |
| Liberty PeptidesCASE #VI-2026-0416 | X | 1 | 3.0 | 3.0 | 3.0 | 16 Mar 2025 | 16 Mar 2025 |
| Oasis PeptidesCASE #VI-2026-0404 | X | 1 | 2.9 | 2.9 | 2.9 | 21 May 2025 | 21 May 2025 |
| Chimera PeptidesCASE #VI-2026-0260 | X | 1 | 2.5 | 2.5 | 2.5 | 9 Jun 2025 | 9 Jun 2025 |
| Lejian Biotech PeptideCASE #VI-2026-0746 | X | 1 | 0.0 | 0.0 | 0.0 | 8 Jul 2025 | 8 Jul 2025 |
| HK Fat CatCASE #VI-2026-0376 | X | 1 | 0.0 | 0.0 | 0.0 | 27 Feb 2025 | 27 Feb 2025 |
| Explicit SarmsCASE #VI-2026-0017 | X | 1 | 0.0 | 0.0 | 0.0 | 21 May 2025 | 21 May 2025 |
| Wuhan Newtop BiotechCASE #VI-2026-0676 | X | 1 | 0.0 | 0.0 | 0.0 | 3 Jul 2025 | 3 Jul 2025 |
Open any subject to view the batch-level evidence for Chonluten alone.